|
Consolidated Statements of Operations (Unaudited) (USD $)
|
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
|
Sep. 30, 2011
|
Sep. 30, 2010
|
Sep. 30, 2011
|
Sep. 30, 2010
|
|
| Income Statement [Abstract] | ||||
| Sales | $ 3,930,503 | $ 4,515,222 | $ 8,937,818 | $ 11,133,223 |
| Cost of sales | (2,144,952) | (2,400,005) | (4,668,316) | (5,555,191) |
| Gross profit | 1,785,551 | 2,115,217 | 4,269,502 | 5,578,032 |
| Operating Expenses: | ||||
| General and adminstrative expenses | 3,792,480 | 1,684,248 | 6,884,039 | 4,461,004 |
| Depreciation expense | 205,352 | 87,867 | 372,002 | 249,473 |
| Research and development expenses | 4,011 | 54,837 | 119,167 | 149,497 |
| Total Operating Expenses | 4,001,843 | 1,826,952 | 7,375,208 | 4,859,974 |
| Income (Loss) from operations | (2,216,292) | 288,265 | (3,105,706) | 718,058 |
| Interest expense | (283,411) | (123,415) | (505,606) | (323,142) |
| Income (Loss) before provision for income taxes | (2,499,703) | 164,850 | (3,611,312) | 394,916 |
| (Provision) benefit for income taxes | 92,000 | |||
| Net income (loss) including noncontrolling interest | (2,499,703) | 256,850 | (3,611,312) | 394,916 |
| Less: Net income (loss) attributable to noncontrolling interest | (696) | |||
| Net income (loss) attributable to Biozone | $ (2,499,703) | $ 256,850 | $ (3,611,312) | $ 395,612 |
| Income (Loss) per common share | $ (0.04) | $ 0.01 | $ (0.07) | $ 0.01 |
| Basic and diluted weighted average common share outstanding | 67,492,714 | 37,698,000 | 49,112,016 | 37,698,000 |
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating basic and diluted EPS. No definition available.
|
| X | ||||||||||
|
- Definition
Total costs related to goods produced and sold during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to noncontrolling interests, if any, which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items which are apportioned to that ownership interest in subsidiary equity which is not attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cost of borrowed funds accounted for as interest that was charged against earnings during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue during the period from sale of goods in the normal course of business, before deducting returns, allowances and discounts. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|